Login to Your Account



Financings Roundup

Neurotech Brings In $35M For Phase II Retinal Disease Trials

By Trista Morrison


Friday, November 17, 2006
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription